These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1128746)

  • 41. The clinical spectrum of prostate cancer.
    de Vere White R; Paulson DF; Glenn JF
    J Urol; 1977 Mar; 117(3):323-7. PubMed ID: 839594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognosis of the prostatic carcinoma].
    Schröder H; Lisske E
    Bruns Beitr Klin Chir (1971); 1969 Dec; 217(8):750-5. PubMed ID: 5386743
    [No Abstract]   [Full Text] [Related]  

  • 43. Proceedings: The natural history of prostatic cancer.
    Whitmore WF
    Cancer; 1973 Nov; 32(5):1104-12. PubMed ID: 4594097
    [No Abstract]   [Full Text] [Related]  

  • 44. Pattern of care and follow-up of stages A1, B1 prostatic cancers from multicenter group, the National Prostatic Cancer Treatment Group (NPCTG).
    Murphy GP; Gaeta J; Priore R
    Urology; 1987 Mar; 29(3):258-61. PubMed ID: 3824720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.
    Battaglia S; Barbolini G; Botticelli AR
    Virchows Arch A Pathol Anat Histol; 1979 Jun; 382(3):245-9. PubMed ID: 160657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contribution of subclinical cancer to Denver's high prostatic cancer incidence rate.
    Beckner M; Berg JW; Franz LW
    J Chronic Dis; 1985; 38(3):225-31. PubMed ID: 3988880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radical Surgery for Prostatic Cancer.
    Walsh PC; Jewett HJ
    Cancer; 1980 Apr; 45 Suppl 7():1906-1911. PubMed ID: 29603168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [ON THE SURGICAL TREATMENT OF PROSTATIC CANCER].
    COUVELAIRE R
    Urol Int; 1965; 19():63-6. PubMed ID: 14295219
    [No Abstract]   [Full Text] [Related]  

  • 49. Being on active surveillance: the patient perspective.
    Mastris K; Denis L
    Transl Androl Urol; 2018 Feb; 7(1):182-187. PubMed ID: 29594032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients.
    Shoji K; Teishima J; Hayashi T; Shinmei S; Akita T; Sentani K; Takeshima Y; Arihiro K; Tanaka J; Yasui W; Matsubara A
    Oncol Lett; 2017 Jul; 14(1):299-305. PubMed ID: 28693168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anatomic imaging of the prostate.
    Bhavsar A; Verma S
    Biomed Res Int; 2014; 2014():728539. PubMed ID: 25243174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multisector dosimetry in the immediate post-implant period: significant under dosage of the prostate base.
    Kirschner AN; Sathiaseelan V; Zhang Y; David J; Kalapurakal JA
    J Contemp Brachytherapy; 2014 Mar; 6(1):33-9. PubMed ID: 24790620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume center.
    Lee DH; Chung DY; Lee KS; Kim IK; Rha KH; Choi YD; Chung BH; Hong SJ; Kim JH
    Yonsei Med J; 2014 Jan; 55(1):78-83. PubMed ID: 24339290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients.
    Kita Y; Shimizu Y; Inoue T; Kamba T; Yoshimura K; Ogawa O
    Int J Clin Oncol; 2013 Aug; 18(4):718-23. PubMed ID: 22791141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-treatment risk stratification of prostate cancer patients: A critical review.
    Rodrigues G; Warde P; Pickles T; Crook J; Brundage M; Souhami L; Lukka H;
    Can Urol Assoc J; 2012 Apr; 6(2):121-7. PubMed ID: 22511420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma free amino acid profiling of five types of cancer patients and its application for early detection.
    Miyagi Y; Higashiyama M; Gochi A; Akaike M; Ishikawa T; Miura T; Saruki N; Bando E; Kimura H; Imamura F; Moriyama M; Ikeda I; Chiba A; Oshita F; Imaizumi A; Yamamoto H; Miyano H; Horimoto K; Tochikubo O; Mitsushima T; Yamakado M; Okamoto N
    PLoS One; 2011; 6(9):e24143. PubMed ID: 21915291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoma of the Prostate: Screening and investigative techniques and treatments.
    Donnelly BJ
    Can Fam Physician; 1991 Apr; 37():943-9. PubMed ID: 21229074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel diagnostic biomarkers for prostate cancer.
    Madu CO; Lu Y
    J Cancer; 2010 Oct; 1():150-77. PubMed ID: 20975847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
    Rajab R; Fisher G; Kattan MW; Foster CS; Møller H; Oliver T; Reuter V; Scardino PT; Cuzick J; Berney DM;
    Mod Pathol; 2011 Jan; 24(1):58-63. PubMed ID: 20834240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bayesian inference for the stereotype regression model: Application to a case-control study of prostate cancer.
    Ahn J; Mukherjee B; Banerjee M; Cooney KA
    Stat Med; 2009 Nov; 28(25):3139-57. PubMed ID: 19731262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.